Rieko Ishima, PhD

Summary

I am the principal investigator of an R21 grant titled Development of a biparatopic-domain antibody screening system, with the long-term goal of developing MSLN-targeting domain antibodies that will be utilized to design therapeutic reagents. I am also collaborating on a project involving Src-family kinase.